MeVis Medical Solutions AG

Board/Management Information • Apr 16, 2015

News Details

Corporate | 16 April 2015 11:05

MeVis Medical Solutions AG: Changes in the Supervisory Board of MeVis Medical Solutions AG

MeVis Medical Solutions AG / Key word(s): Change of Personnel

2015-04-16 / 11:05

---

• Prof. Dr. Peitgen and Mr. Kuhlmann-Lehmkuhle resign from office in light of the acquisition of a majority stake by Varian Medical Systems
• Succession candidates proposed
• Dr. Kruse remains Supervisory Board Member
• Election of two new Supervisory Board Members at the AGM on June 9th.

Bremen, April 16, 2015 – Prof. Dr. Heinz-Otto Peitgen, Chairman of the Supervisory Board of MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], and Mr. Peter Kuhlmann-Lehmkuhle, Member of the Supervisory Board of MeVis Medical Solutions AG, informed the Company this past Friday that, in light of the acquisition of a majority stake in the Company by VMS Deutschland Holdings GmbH, they will resign from their respective offices effective as of the end of the Annual General Meeting on June 9, 2015. Two succession candidates with executive positions at Varian are being proposed.

Prof. Dr. Peitgen, Chairman of the Supervisory Board of MeVis Medical Solutions AG since September 2006, is one of the founders of the Company and has significantly influenced the development of MeVis Medical Solutions AG to become one of the world’s leading software companies in medical imaging for diagnosis and treatment of cancer. During his time as Chairman of the Supervisory Board, the IPO of MeVis Medical Solutions AG was successfully implemented on November 16, 2007. Mr. Kuhlmann-Lehmkuhle has been a Member of the Supervisory Board since June 2011.

“I founded MeVis with some of my employees in 1997 and accompanied it through 18 years in good and in challenging times,” says Prof. Dr. Peitgen. “I am pleased that now, with me having reached the age of 70, MeVis, a healthy company with excellent annual results, is in very good hands through the acquisition of a majority of shares by Varian Medical Systems, and thus has the opportunity to expand its position in the world market. Today I thank especially the staff and the Executive Board, who have made the company what it is today, and I wish them all the best for the future.”

The Executive Board would like to thank Prof. Dr. Peitgen sincerely for many years of extraordinary commitment as founder and Chairman of the Supervisory Board of the Company. The Executive Board also thanks Mr. Kuhlmann-Lehmkuhle for his constructive contributions over the past four years.

The Supervisory Board has decided to propose Mr. Jörg Fässler and Mr. Glen Hilton, both in responsible executive positions at Varian Medical Systems, as Members of the Supervisory Board at the Annual General Meeting on June 9, 2015. Dr. Jens Kruse will remain a Member of the Supervisory Board.

---

2015-04-16 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language:	English
Company:	MeVis Medical Solutions AG
	Caroline-Herschel-Str. 1
	28359 Bremen
	Germany
Phone:	+49 421 224 95 0
Fax:	+49 421 224 95 999
E-mail:	ir@mevis.de
Internet:	http://www.mevis.de
ISIN:	DE000A0LBFE4
WKN:	A0LBFE
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart

End of News	DGAP News-Service

- - -
344867  2015-04-16